Comparison of Aclidinium Bromide and Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Public ClinicalTrials.gov record NCT00706914. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Active-Controlled, Parallel-Group, Multicenter, 4-Week Pilot Study to Assess Symptoms in Stable, Moderate to Severe COPD Patients Taking Aclidinium Bromide 200 mcg Once Daily in Combination With Formoterol Fumarate Once or Twice Daily Versus Formoterol Fumarate Twice Daily
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This exploratory study will compare the efficacy of the fixed-dose combination (FDC) of aclidinium bromide and formoterol fumarate once daily in the morning and placebo once in the evening vs. the FDC once daily in the morning and formoterol fumarate once in the evening vs. formoterol fumarate twice daily. The study will assess pulmonary function and symptoms in patients with moderate to severe COPD.
Study identification
- NCT ID
- NCT00706914
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 156 participants
Conditions and interventions
Conditions
Interventions
- Once-daily aclidinium/formoterol Drug
- Twice-daily formoterol fumarate Drug
- Placebo to formoterol fumarate Drug
- Once-daily formoterol fumarate Drug
Drug
Eligibility (public fields only)
- Age range
- 40 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2008 (Actual)
- Primary completion
- Nov 11, 2008 (Actual)
- Completion
- Nov 11, 2008 (Actual)
- Last update posted
- May 15, 2017
2008
United States locations
- U.S. sites
- 40
- U.S. states
- 21
- U.S. cities
- 39
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Forest Investigative Site | Tucson | Arizona | 85715 | — |
| Forest Investigative Site | Tucson | Arizona | 85741 | — |
| Forest Investigative Site | Fullerton | California | 92835 | — |
| Forest Investigative Site | Lakewood | California | 90712 | — |
| Forest Investigative Site | Rancho Mirage | California | 92270 | — |
| Forest Investigative Site | Redlands | California | 92373 | — |
| Forest Investigative Site | San Diego | California | 92120 | — |
| Forest Investigative Site | San Jose | California | 95124 | — |
| Forest Investigative Site | Stockton | California | 95207 | — |
| Forest Investigative Site | Wheat Ridge | Colorado | 80033 | — |
| Forest Investigative Site | Hartford | Connecticut | 06105 | — |
| Forest Investigative Site | New Britain | Connecticut | 06053 | — |
| Forest Investigative Site | Waterbury | Connecticut | 06708 | — |
| Forest Investigative Site | DeLand | Florida | 32720 | — |
| Forest Investigative Site | Panama City | Florida | 32405 | — |
| Forest Investigative Site | Tamarac | Florida | 33321 | — |
| Forest Investigative Site | Tampa | Florida | 33603 | — |
| Forest Investigative Site | Atlanta | Georgia | 30342 | — |
| Forest Investigative Site | Austell | Georgia | 30106 | — |
| Forest Investigative Site | Blue Ridge | Georgia | 30513 | — |
| Forest Investigative Site | Bowling Green | Kentucky | 42101 | — |
| Forest Investigative Site | Hazard | Kentucky | 41701 | — |
| Forest Investigative Site | North Dartmouth | Massachusetts | 02747 | — |
| Forest Investigative Site | Rochester | Minnesota | 55905 | — |
| Forest Investigative Site | Florissant | Missouri | 63033 | — |
| Forest Investigative Site | Saint Charles | Missouri | 63301 | — |
| Forest Investigative Site | St Louis | Missouri | 63110 | — |
| Forest Investigative Site | Albany | New York | 12205 | — |
| Forest Investigative Site | Charlotte | North Carolina | 28207 | — |
| Forest Investigative Site | Cincinnati | Ohio | 45242 | — |
| Forest Investigative Site | Columbus | Ohio | 43215 | — |
| Forest Investigative Site | Medford | Oregon | 97504 | — |
| Forest Investigative Site | Pittsburgh | Pennsylvania | 15213 | — |
| Forest Investigative Site | East Providence | Rhode Island | 02914 | — |
| Forest Investigative Site | Spartanburg | South Carolina | 29303 | — |
| Forest Investigative Site | Dallas | Texas | 75246 | — |
| Forest Investigative Site | McKinney | Texas | 75069 | — |
| Forest Investigative Site | Midvale | Utah | 84047 | — |
| Forest Investigative Site | Richmond | Virginia | 23225 | — |
| Forest Investigative Site | Milwaukee | Wisconsin | 53209 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00706914, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 15, 2017 · Synced Oct 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00706914 live on ClinicalTrials.gov.